← Leaderboards
Sandra Aung
Ubivac, Llc
$2,270,463
Attributed
$2,270,463
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $760.2K · FY2006–11$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,270,463 · 2
By mechanism
R44$2,118,266 · 1
R43$152,197 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Adenocarcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$39,462,948
- Anirban Maitra · Johns Hopkins University$30,605,004
- Richard M Peek · Vanderbilt University Medical Center$23,246,493
- Gloria M. Petersen · Johns Hopkins University$21,134,227
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$19,098,764
- Dean E. Brenner · University Of Michigan At Ann Arbor$18,393,816
Research focus
AdenocarcinomaAgonistAllogenicAnimal ModelAnimalsAntibody FormationAntigen Presentation PathwayAntigen-Presenting CellsAntigensAntitumor ResponseAutologousAwardBaseBinding (Molecular Function)BiomarkerBullaBusinessesCancer VaccinesCd8b1 GeneCell BankCell CountCell LineCellsAccounting
Grant awards (4)
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$672,271
R44 · FY2011 · CA · contact PI
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$685,832
R44 · FY2010 · CA · contact PI
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$760,163
R44 · FY2009 · CA · contact PI
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$152,197
R43 · FY2006 · CA · contact PI